Form 4: Hims & Hers Health COO Melissa Baird Executes Stock Option and Sells Shares
SEC Form 4 Filing
Chief Operating Officer of Hims & Hers Health, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on April 9, 2025, according to a Form 4 filing with the SEC.
Summary
- Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc., executed stock options to acquire 33,337 shares of Class A Common Stock at a price of $1.75 on April 9, 2025.
- On the same day, Baird sold a total of 33,337 shares of Class A Common Stock in multiple transactions at prices ranging from $25.8234 to $29.2258.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 26, 2024.
- Following these transactions, Baird directly owns 805,083 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions. The use of a 10b5-1 plan suggests a pre-planned strategy, reducing potential negative interpretations.
Industry Context
This filing is a routine disclosure of insider transactions and provides insight into the trading activity of a key executive at Hims & Hers Health. It is common for executives to utilize 10b5-1 trading plans to manage their stock holdings and avoid accusations of insider trading.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly traded companies.
- Executives often use Rule 10b5-1 plans to schedule stock sales in advance, which is a standard practice to avoid potential conflicts of interest.
- Comparable companies like Teladoc Health or GoodRx also have executives who regularly report stock transactions via Form 4 filings.
Stakeholder Impact
- The stock sales could have a minor impact on the stock price, depending on market perception.
- The transactions provide transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 2021 | Company's business combination transaction; option converted into the right to purchase 113,245 shares of the Company with an exercise price of $1.75. |
| 11/26/2024 | Date of adoption of Rule 10b5-1 trading plan. |
| 04/09/2025 | Date of stock option exercise and stock sales. |
| 04/10/2025 | Date of signature on the Form 4 filing. |
| 11/06/2029 | Expiration date of the stock option. |
Keywords
Form 4, Hims & Hers Health, Melissa Baird, Stock Options, Class A Common Stock, SEC Filing, Rule 10b5-1, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.